BMS 806 is primarily used in research settings to study its effects on viral entry mechanisms. It has shown potential as an inhibitor of HIV-1 entry by targeting the gp120 envelope protein, which plays a critical role in the virus's ability to infect host cells. This makes it a valuable tool for understanding the molecular interactions involved in HIV infection and for developing potential antiviral therapies. Researchers utilize BMS 806 to explore its efficacy in blocking viral fusion and to assess its potential as a lead compound for drug development. Its application is largely confined to preclinical studies, where it aids in the investigation of novel therapeutic strategies against HIV and related retroviruses.